- Home
- RARE vs YELP Comparison
RARE vs YELP Comparison
Compare RARE & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | YELP |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2013 | 2011 |
Fundamental Metrics
Financial Performance| Metric | RARE | YELP |
|---|---|---|
| Price | $23.18 | $21.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 6 |
| Target Price | ★ $66.32 | $29.17 |
| AVG Volume (30 Days) | ★ 2.1M | 1.7M |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.31 | ★ 39.26 |
| EPS | N/A | ★ 1.63 |
| Revenue | $673,000,000.00 | ★ $1,412,064,000.00 |
| Revenue This Year | $17.23 | $4.58 |
| Revenue Next Year | $36.13 | $3.00 |
| P/E Ratio | ★ N/A | $13.51 |
| Revenue Growth | ★ 20.13 | 5.61 |
| 52 Week Low | $18.41 | $19.60 |
| 52 Week High | $43.22 | $40.25 |
Technical Indicators
Market Signals| Indicator | RARE | YELP |
|---|---|---|
| Relative Strength Index (RSI) | 48.43 | 39.65 |
| Support Level | $22.00 | N/A |
| Resistance Level | $25.46 | $33.67 |
| Average True Range (ATR) | 1.29 | 1.04 |
| MACD | 0.25 | 0.15 |
| Stochastic Oscillator | 72.03 | 49.64 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About YELP Yelp Inc.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.